Evaluation and Management of Iron Deficiency with Microscopic Hematuria
In a woman with iron deficiency and microscopic hematuria (a few RBCs on urinalysis), you must pursue gastrointestinal evaluation with bidirectional endoscopy to exclude malignancy, as iron deficiency in the absence of menstrual losses or other known iron losses should trigger careful assessment for GI bleeding. 1
Initial Diagnostic Workup
Confirm Iron Deficiency
- Measure serum ferritin and transferrin saturation (TSAT)
- In the absence of inflammation, ferritin <45 ng/mL confirms iron deficiency 2
- TSAT <20% has high sensitivity for diagnosing absolute or functional iron deficiency 3
- If inflammatory conditions are present, ferritin may be elevated despite iron deficiency; in these cases, use TSAT <20% as your primary marker or consider soluble transferrin receptor 4
Assess the Hematuria
- Define microscopic hematuria as >3 RBC/HPF on microscopic evaluation of a properly collected urine specimen 5
- Dipstick testing alone is insufficient—always confirm with microscopic evaluation 5
- Perform history and physical examination focusing on:
- Risk factors for genitourinary malignancy (age, smoking history, degree of hematuria)
- Medical renal disease indicators (hypertension, proteinuria)
- Gynecologic causes (menstrual history, pelvic examination)
- Non-malignant GU causes 5
Critical Decision Point: GI vs. GU Evaluation Priority
The finding of iron deficiency in a patient with microscopic hematuria mandates GI evaluation first, as this combination strongly suggests occult GI bleeding rather than isolated urologic pathology. 1
Proceed with GI Evaluation:
Bidirectional endoscopy (upper endoscopy with small bowel biopsy AND colonoscopy) is strongly recommended for:
Test for H. pylori noninvasively if bidirectional endoscopy is negative; treat if positive 2
Screen for celiac disease with serologic testing, followed by small bowel biopsy only if positive 2
Urologic Evaluation Timing:
After addressing GI causes, proceed with urologic evaluation based on hematuria risk stratification 5:
Low-risk patients (younger women without smoking history, minimal hematuria): May undergo repeat urinalysis in 6 months or cystoscopy with urinary tract ultrasound through shared decision-making 7
Intermediate-risk patients: Cystoscopy and urinary tract ultrasound recommended 7
High-risk patients (age >35, smoking history, >25 RBC/HPF): Cystoscopy and axial upper urinary tract imaging 5, 7
Iron Repletion Strategy
Oral Iron (First-Line for Most Patients)
- Ferrous sulfate, ferrous fumarate, or ferrous gluconate are reasonable first choices 4
- Take on empty stomach when possible; if not tolerated, take with meals (preferably with meat protein and 500 mg vitamin C) 4
- Monitor hemoglobin in 4-8 weeks; expect 1-2 g/dL increase 3
- Continue for 3-6 months after hemoglobin normalizes to replenish iron stores
Intravenous Iron (Consider When):
- Oral iron not tolerated or ineffective
- Malabsorption present (celiac disease, inflammatory bowel disease)
- Severe anemia requiring rapid correction
- Chronic kidney disease (especially if on dialysis) 8
- Chronic heart failure with iron deficiency 8
Follow-Up Protocol
Repeat hemoglobin and ferritin in 4-8 weeks after starting iron therapy 3
If no response to oral iron after 4-8 weeks, consider:
- Non-compliance
- Ongoing blood loss
- Malabsorption
- Incorrect diagnosis
- Need for IV iron
For persistent hematuria after negative GI workup: Repeat urinalysis in 6-12 months depending on risk stratification 5, 7
Common Pitfalls to Avoid
- Do not assume hematuria explains iron deficiency without GI evaluation—microscopic hematuria rarely causes clinically significant blood loss sufficient to produce iron deficiency
- Do not rely on dipstick alone for hematuria diagnosis 5
- Do not use ferritin alone in inflammatory states—it's an acute phase reactant and may be falsely elevated 1, 3
- Do not defer endoscopy in premenopausal women solely based on age—while malignancy risk is lower, it's not zero, and other treatable GI causes (celiac disease, H. pylori) are common 2
- Do not stop anticoagulation for hematuria workup—evaluate these patients the same as those not on anticoagulants 5